Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
06/29/2000 | WO2000037676A1 Method of sequence identification |
06/29/2000 | WO2000037675A2 Reporter gene assay for compounds which mimic or inhibit the physiological effect of the ob-protein |
06/29/2000 | WO2000037667A1 Method for producing ascorbic acid intermediates |
06/29/2000 | WO2000037664A1 Method for preparing suspension of stable posiplexes |
06/29/2000 | WO2000037663A2 Plant transformation process |
06/29/2000 | WO2000037662A2 S-adenosyl-l-methionine synthetase promoter and its use in expression of transgenic genes in plants |
06/29/2000 | WO2000037661A1 GENETIC MODIFICATION OF $i(COMPOSITAE) |
06/29/2000 | WO2000037660A1 Methods and genetic compositions to limit outcrossing and undesired gene flow in crop plants |
06/29/2000 | WO2000037659A1 Non-viral transfection vector |
06/29/2000 | WO2000037658A2 Chemically modified enzymes with multiple charged variants |
06/29/2000 | WO2000037657A1 Process for the enzymatic preparation of amino acid derivatives with enhanced optical purity |
06/29/2000 | WO2000037656A2 Flavonoid biosynthetic enzymes |
06/29/2000 | WO2000037655A1 Mammalian lysophosphatidic acid acyltransferase |
06/29/2000 | WO2000037654A2 Phenol oxidizing enzymes from funghi |
06/29/2000 | WO2000037653A1 Structural basis for pterin function in nitric oxide synthase |
06/29/2000 | WO2000037652A2 Flavonoid biosynthetic enzymes |
06/29/2000 | WO2000037651A2 Method of screening for agrochemicals |
06/29/2000 | WO2000037650A1 Hepatitis y virus |
06/29/2000 | WO2000037649A2 Dna vaccine against infectious bursal disease virus |
06/29/2000 | WO2000037648A1 Protective antigen of group a streptococci (spa) |
06/29/2000 | WO2000037647A1 Abc transporter and genes encoding the same |
06/29/2000 | WO2000037646A2 Group b streptococcus proteins, and their use |
06/29/2000 | WO2000037645A2 Cell cycle nucleic acids, polypeptides and uses thereof |
06/29/2000 | WO2000037644A1 Sodium/proton countertransporter gene |
06/29/2000 | WO2000037643A2 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
06/29/2000 | WO2000037642A1 Method of enhancing the biological activity of ligands |
06/29/2000 | WO2000037641A2 Vascular endothelial growth factor-x |
06/29/2000 | WO2000037640A2 Compositions and methods for the treatment of tumor |
06/29/2000 | WO2000037639A2 Lymphocytic membrane proteins |
06/29/2000 | WO2000037638A2 Methods and compositions for inhibiting neoplastic cell growth |
06/29/2000 | WO2000037637A1 Novel protein and dna thereof |
06/29/2000 | WO2000037636A1 Socs-box containing peptides |
06/29/2000 | WO2000037635A2 Genetic suppressor elements against human immunodeficiency virus |
06/29/2000 | WO2000037633A1 Rna polymerase transcription promoters and method for determining base sequence |
06/29/2000 | WO2000037632A1 Monoclonal antibody against apolipoprotein a-i |
06/29/2000 | WO2000037631A1 Process for the production of enzymes with altered catalytic activity relative to an amino acid substrate and enzymes so produced |
06/29/2000 | WO2000037629A2 Method of producing antihypercholesterolemic agents |
06/29/2000 | WO2000037628A1 Microsystem for cell permeation and cell fusion |
06/29/2000 | WO2000037627A1 Subtilase enzymes of the i-s1 and i-s2 sub-groups having an additional amino acid residue in an active site loop region |
06/29/2000 | WO2000037626A1 Subtilase enzymes of the i-s1 and i-s2 sub-groups having an additional amino acid residue in an active site loop region |
06/29/2000 | WO2000037625A1 Subtilase enzymes of the i-s1 and i-s2 sub-groups having an additional amino acid residue in an active site loop region |
06/29/2000 | WO2000037624A1 Subtilase enzymes of the i-s1 and i-s2 sub-groups having an additional amino acid residue in an active site loop region |
06/29/2000 | WO2000037623A1 Subtilase enzymes of the i-s1 and i-s2 sub-groups having an additional amino acid residue in an active site loop region |
06/29/2000 | WO2000037622A1 Subtilase enzymes of the i-s1 and i-s2 sub-groups having an additional amino acid residue in an active site loop region |
06/29/2000 | WO2000037621A1 Subtilase enzymes of the i-s1 and i-s2 sub-groups having an additional amino acid residue in an active site loop region |
06/29/2000 | WO2000037619A2 Mutant epoxide hydrolases |
06/29/2000 | WO2000037618A1 Thermostabile polymerase obtained from iss 1/1 |
06/29/2000 | WO2000037617A1 Glutamine: fructose-6-phosphate aminotransferase ii enzyme and their encoding nucleic acids |
06/29/2000 | WO2000037615A1 Recombinant synthesis of beta-lipotropin and other peptides |
06/29/2000 | WO2000037614A2 Variants of egiii-like cellulase and compositions thereof |
06/29/2000 | WO2000037613A2 Human akt-3 |
06/29/2000 | WO2000037612A1 SOMATIC CELLS WITH ABLATED Prp GENE AND METHODS OF USE |
06/29/2000 | WO2000037611A1 Cell lineage markers |
06/29/2000 | WO2000037610A2 Expression of immunogenic hepatitis b surface antigens in transgenic plants |
06/29/2000 | WO2000037609A2 Orally immunogenic bacterial enterotoxins expressed in transgenic plants |
06/29/2000 | WO2000037608A2 Micromonospora echinospora genes encoding for biosynthesis of calicheamicin and self-resistance thereto |
06/29/2000 | WO2000037599A1 Subtilase enzymes of the i-s1 and i-s2 sub-groups having an additional amino acid residue in the active site loop region |
06/29/2000 | WO2000037504A2 Human monoclonal antibodies to ctla-4 |
06/29/2000 | WO2000037503A1 Compositions and methods for generating monoclonal antibodies representative of a specific cell type |
06/29/2000 | WO2000037502A2 Vascular endothelial cell growth factor antagonists and uses thereof |
06/29/2000 | WO2000037498A1 THE POLYPEPTIDE DREAM, USED AS Ca2+IONS-DEPENDENT TRANSCRIPTIONAL REGULATOR AND ITS GENE CODING THEREFOR |
06/29/2000 | WO2000037497A1 Sugar transporter and gene encoding the same |
06/29/2000 | WO2000037495A1 EF-Tu |
06/29/2000 | WO2000037494A2 Chlamydia trachomatis antigens |
06/29/2000 | WO2000037493A2 Type iii secretion system antigens from bordetella pertussis |
06/29/2000 | WO2000037491A2 Dnas encoding proteins with signal sequences |
06/29/2000 | WO2000037490A2 Outer surface proteins, their genes, and their use |
06/29/2000 | WO2000037488A2 Mads-box genes and uses thereof |
06/29/2000 | WO2000037487A1 αvβ6 INTEGRIN INHIBITORS |
06/29/2000 | WO2000037483A1 Protein-protein interactions in neurodegenerative disorders |
06/29/2000 | WO2000037163A1 Integrated portable biological detection system |
06/29/2000 | WO2000037111A1 Mammalian cell preparations optionally transfected with a gene coding for an active substance containing same |
06/29/2000 | WO2000037104A1 Improved recombinant hepatitis b surface antigen |
06/29/2000 | WO2000037102A2 Improvement of tolerance to a xenograft |
06/29/2000 | WO2000037094A2 Therapeutic applications of flint polypeptides |
06/29/2000 | WO2000037093A1 Bone resorption inhibitors |
06/29/2000 | WO2000037060A2 Transgenic plants comprising a conditionally lethal gene |
06/29/2000 | WO2000037025A2 Antibodies to truncated vegf-d and uses thereof |
06/29/2000 | WO2000036919A1 Bone sialoprotein based toxic gene therapy for the treatment of calcified tumors and tissues |
06/29/2000 | WO2000036911A2 Method for the regeneration of cotton |
06/29/2000 | WO2000036910A1 Msh5 ablated mice and uses therefor |
06/29/2000 | WO2000018907A3 Antisense-sequences for inhibiting the expression of the adhesion molecule icam-1 |
06/29/2000 | WO2000017221A9 Method of measuring protein-protein interactions in living cells |
06/29/2000 | WO2000015809A3 Uracil permease from arabidopsis as herbicidal target gene |
06/29/2000 | WO2000014262A3 Methylation of plasmid vectors |
06/29/2000 | WO2000012726A3 Rationally designed heparinases derived from heparinase i and ii |
06/29/2000 | WO2000012175A3 Methimazole derivatives and tautomeric cyclic thiones to treat autoimmune diseases |
06/29/2000 | WO2000008187A3 Genes involved in tolerance to environmental stress |
06/29/2000 | WO2000008180A3 HUMAN cDNAs ENCODING POLYPEPTIDES HAVING KINASE FUNCTIONS |
06/29/2000 | WO2000008155A3 Human receptor-associated proteins |
06/29/2000 | WO2000008145A3 Novel genes in control of hematopoiesis |
06/29/2000 | WO2000006737A3 Streptococcus pneumoniae proteins and nucleic acid molecules |
06/29/2000 | WO2000006717A3 Improved transformation efficiency in phage display through modification of a coat protein |
06/29/2000 | WO2000006605A3 Heterominibodies |
06/29/2000 | WO2000005373A3 Methods and compositions for the diagnosis and treatment of body weight disorders, including obesity |
06/29/2000 | WO2000002996A3 Recombinant constructs and systems for secretion of proteins via type iii secretion systems |
06/29/2000 | WO2000001817A3 Mammalian genes; dendritic cell prostaglandin-like transponder (dc-pgt), hdtea84, hsljd37r and rankl, hcc5 chemokine, deubiquitinating 11 and 12 (dub11, dub12), md-1, md2 and cyclin e2, related reagents and methods |
06/29/2000 | WO2000000610A3 Human signal peptide-containing proteins |
06/29/2000 | WO2000000594A3 Human transferases |
06/29/2000 | WO1999067415A9 Novel molecules of the t110-related protein family and uses thereof |